Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

A Single-Center Study of the Use of Ranibizumab Biosimilars: Dong Gyu Na, Chul Gu Kim, Jong Woo Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2025;66(6):253-259. Published online June 15, 2025; DOI: https://doi.org/10.3341/jkos.2025.66.6.253; Full text PubReader ePub PDF

Short-term Clinical Outcomes of Ranibizumab Biosimilar SB11 Therapy in Neovascular Age-related Macular Degeneration: Dong Gyu Na, Chul Gu Kim, Jong Woo Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2025;66(5):224-232. Published online May 15, 2025; DOI: https://doi.org/10.3341/jkos.2025.66.5.224; Full text PubReader ePub PDF

Predictive Factors for Retreatment after Intravitreal Ranibizumab Injection to Treat Type 1 Retinopathy of Prematurity: Su Hwan Park, Iksoo Byon, Han Jo Kwon; J Korean Ophthalmol Soc. 2023;64(9):793-802. Published online September 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.9.793; Full text PubReader ePub PDF

Comparison of Intravitreal Bevacizumab and Ranibizumab Injections in Aggressive and Type 1 Retinopathy of Prematurity: Kyumin Kang, Ji Hye Jang; J Korean Ophthalmol Soc. 2023;64(9):784-792. Published online September 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.9.784; Full text PubReader ePub PDF

Course of Neovascular Age-related Macular Degeneration that Showed Limited Response to Both Ranibizumab and Aflibercept: Jeong Seop Yun, Chul Gu Kim, Jong Woo Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2023;64(4):313-322. Published online April 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.4.313; Full text PubReader ePub PDF

Case Reports

Recurrent Idiopathic Choroidal Neovascularization in an Adolescent: Hayoung Lee, Jaehyuk Lee, Jongwon Moon; J Korean Ophthalmol Soc. 2023;64(2):158-163. Published online February 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.2.158; Full text PubReader ePub PDF

Original Articles

Intraocular Cytokine Changes in Patients with Polypoidal Choroidal Vasculopathy Treated with Ranibizumab: Youna Choi, So Hee Kim, Seung Kwon Choi et al.; J Korean Ophthalmol Soc. 2022;63(2):166-174. Published online February 15, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.2.166; Full text PubReader ePub PDF

Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration: Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim; J Korean Ophthalmol Soc. 2021;62(8):1076-1083. Published online August 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.8.1076
Web of Science 3 Crossref 5; Full text PubReader ePub PDF

One-year Outcomes of a Treat-and-extend of Ranibizumab for Naive Exudative Age-related Macular Degeneration: Retrospective Analysis: Young-Je Choi, Woong-Sun Yoo, Yong-Wun Cho, Yu-Jin Choi, In Young Chung; J Korean Ophthalmol Soc. 2021;62(7):939-947. Published online July 15, 2021; DOI: https://doi.org/10.3341/jkos.2021.62.7.939
Crossref 1; Full text PubReader ePub PDF

Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration.: Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(8):758-764. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.758
Web of Science 2 Crossref 4; PDF

Intravitreal Injection of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration: a Systematic Review.: Min Joo Kang, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(8):748-757. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.748; PDF

Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema.: Jangmi Yang, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(7):667-675. Published online July 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.7.667
Web of Science 3 Crossref 5; PDF

Use of Anti-vascular Endothelial Growth Factors for Diabetic Retnopathy: National Health Insurance Claims Data.: Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(7):661-666. Published online July 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.7.661
Web of Science 2 Crossref 9; PDF

Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept.: Tae Kyu Moon, Jun Young Ha, Mi Sun Sung, Sang Woo Park; J Korean Ophthalmol Soc. 2019;60(4):362-368. Published online April 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.4.362; PDF

Prevalence of Exudative Age-related Macular Degeneration and Projections of the Cost of Ranibizumab in Korea.: Sunyoung Ryu, Dong Wook Kim, Tyler Hyungtaek Rim, Eun Jee Chung, Jiwon Kim; J Korean Ophthalmol Soc. 2019;60(3):253-260. Published online March 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.3.253
Web of Science 3 Crossref 5; PDF

Volume 67, No. 1

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

2,509	Risk Factors for Choroidal Detachment and Flat Anterior Chamber Following Ahmed Valve Implantation
5,137	Self-assessment of Visual Acuity Using a Smartphone Application
3,495	Accuracy of Intraocular Lens Power Prediction Using 9 Formula
3,078	Genetic Characteristics of 63 Patients with Non-syndromic Retinitis Pigmentosa at a Single Korean Institution
1,024	Comparison of Scleral Depression in Vitrectomy for Rhegmatogenous Retinal Detachment Under a Wide-Angle Viewing System

Cited By 3	A Case of Retinal Vasculitis, Uveitis in Myelin Oligodendrocyte Glycoprotein Antibody Associated Optic Neuritis
Cited By 3	The Effect of Topical Rebamipide 2% in Managing Dry Eye Following Cataract Surgery
Cited By 2	Comparison of Clinical Outcomes Among Sutured, Sutureless Scleral Fixation, and Retropupillary Fixation of Intraocular Lens
Cited By 1	Accuracy of Intraocular Lens Power Prediction Using 9 Formula
Cited By 1	Clinical Outcomes of Topical Bromfenac Combined with Intravitreal Aflibercept Injection for Exudative Age-related Macular Degeneration

Editorial Office: #1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603 Fax: +82-2-2277-5194 E-mail: kos@ijpnc.com

Copyright © 2026 by Korean Ophthalmological Society.

prev

next